3,3-dimethyl-1-(4-methyl-1-piperazinyl)-2-butanone | 80354-62-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪烷类
• 英文名称: 3,3-dimethyl-1-(4-methyl-1-piperazinyl)-2-butanone
• 英文别名: 3,3-Dimethyl-1-(4-methylpiperazin-1-yl)butan-2-one
• CAS: 80354-62-7
• 化学式: C₁₁H₂₂N₂O
• mdl: MFCD12145936
• 分子量: 198.308
• InChiKey: RQVYBSKASWOBFB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.2
• 重原子数：
  14
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.909
• 拓扑面积：
  23.6
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  3,3-dimethyl-1-(4-methyl-1-piperazinyl)-2-butanone 在 氢氧化钾 、 一水合肼 作用下， 生成 1-(3,3-dimethylbutyl)-4-methylpiperazine
  参考文献：
  名称：

  Lukevits, E.; Liepin'sh, E.; Popova, E. P., Journal of general chemistry of the USSR, 1980, vol. 50, # 2, p. 317 - 324

  摘要：

  DOI：
• 作为产物：
  描述：

  1-溴频哪酮 、 N-甲基哌嗪 生成 3,3-dimethyl-1-(4-methyl-1-piperazinyl)-2-butanone
  参考文献：
  名称：

  Lukevits, E.; Liepin'sh, E.; Popova, E. P., Journal of general chemistry of the USSR, 1980, vol. 50, # 2, p. 317 - 324

  摘要：

  DOI：

文献信息

• HIV protease inhibiting compounds
  申请人：Flentge Charles A.

  公开号：US20110003827A1

  公开（公告）日：2011-01-06

  A compound of the formula is disclosed as an HIV protease inhibitor. Methods and compositions for inhibiting an HIV infection are also disclosed.

  公开了一种具有以下公式的化合物，作为HIV蛋白酶抑制剂。还公开了抑制HIV感染的方法和组合物。
• Aminophenylsulfonamide Derivatives as Hiv Protease Inhibitor
  申请人：De Kock Herman Augustinus

  公开号：US20080306061A1

  公开（公告）日：2008-12-11

  The present invention concerns substituted aminophenylsulfonamide compounds and derivatives, their use as protease inhibitors, in particular as broadspectrum HIV protease inhibitors, processes for their preparation as well as pharmaceutical compositions and diagnostic kits comprising them. The present invention also concerns combinations of the present substituted aminophenylsulfonamide compounds and derivatives with another anti-retroviral agent. It further relates to their use in assays as reference compounds or as reagents.

  本发明涉及取代的氨基苯磺酰胺化合物及其衍生物，它们的用途为蛋白酶抑制剂，特别是作为广谱HIV蛋白酶抑制剂，以及它们的制备方法、制药组合物和诊断试剂盒。本发明还涉及本发明的取代氨基苯磺酰胺化合物和衍生物与另一种抗逆转录病毒药物的组合。它进一步涉及它们作为参考化合物或试剂在检测中的使用。
• SUBSTITUTED PYRIMIDINES AS ADENOSINE RECEPTOR ANTAGONISTS
  申请人：Lanier Marion

  公开号：US20100234341A1

  公开（公告）日：2010-09-16

  Compounds of formula (I) including pharmaceutically acceptable salts, esters, solvates and stereoisomers thereof, R 1 , R 2 and R 3 are as defined herein. Pharmaceutical compositions containing a compound of structure (I), as well as methods relating to the use thereof, are also disclosed.

  公式（I）的化合物，包括药学上可接受的盐、酯、溶剂和立体异构体，其中R1、R2和R3的定义如本文所述。本发明还公开了含有结构（I）化合物的制药组合物，以及与其使用相关的方法。
• CARBAMOYL DERIVATIVES OF BICYCLIC CARBONYLAMINO-PYRAZOLES AS PRODRUGS
  申请人：Pulici Maurizio

  公开号：US20110118278A1

  公开（公告）日：2011-05-19

  There are provided bicyclic carbonylamino-pyrazoles of formula (I), wherein the variables are as specified in the claims, for use as medicament, in particular for the treatment of diseases due to the malfunctioning of protein kinases (PKs), such as cancer, pharmaceutical compositions comprising such carbamoyl derivatives, and their use as prodrugs of therapeutically active agents. Method of treatment and some new bicyclic carbonylamino-pyrazoles are also object of the present invention.

  本发明提供了式(I)的双环羰基氨基吡唑化合物，其中变量如权利要求中所述，用作药物，特别是用于治疗由蛋白激酶（PKs）功能失调引起的疾病，如癌症，包含此类羰酰基衍生物的制药组合物，并将其用作治疗活性剂的前药。本发明还涉及治疗方法和一些新的双环羰基氨基吡唑化合物。
• HIV PROTEASE INHIBITING COMPOUNDS
  申请人：Flentge Charles A.

  公开号：US20130023463A1

  公开（公告）日：2013-01-24

  A compound of the formula is disclosed as an HIV protease inhibitor. Methods and compositions for inhibiting an HIV infection are also disclosed.

  该化合物的公式被披露为HIV蛋白酶抑制剂。还披露了抑制HIV感染的方法和组合物。